Lhermitte's sign following oxaliplatin-containing chemotherapy in a cisplatin-pretreated ovarian cancer patient [4]

European Journal of Neurology

Volumn 10, Issue 3, 2003, Pages 328-329

  Ciucci, Gabriele ^a   De Giorgi, U ^a   Leoni, M ^a   Bianchedi, G ^a  

^a SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

Author keywords

Cisplatin; Lhermitte's sign; Oxaliplatin; Peripheral neuropathy

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; OXALIPLATIN; PACLITAXEL;

ADULT; CASE REPORT; ELECTRIC SHOCK; ELECTROMYOGRAPHY; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HUMAN; INCIDENCE; LETTER; LHERMITTE DUCLOS DISEASE; MUSCLE REFLEX; NEUROTOXICITY; OVARY CANCER; PRIORITY JOURNAL; SENSORY NEUROPATHY; SYMPTOMATOLOGY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; NECK; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PERIPHERAL NERVOUS SYSTEM DISEASES; ROTATION; SENSATION DISORDERS;

EID: 0038293419     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00579.x     Document Type: Letter

References (4)

1. Howe JF, Loeser JD, Calvin WH (1977). Mechanosensitivity of dorsal root ganglia and chronically injured axons: a physiological basis for the radicular pain of nerve root compression. Pain 3:25-41.
2. Piccart MJ, Lamb H, Vermorken JB (2001). Current and future potential roles of the platinum drugs in the treatment of ovarian cancer. Ann Oncol 12:1195-1203.
3. Roelofs RI, Hrushesky W, Rogin J et al. (1984). Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 34:934-938.
4. Taieb S, Trillet-Lenoir V, Rambaud L et al. (2002). Lhermitte sign and urinary retention, atypical presentation of oxaliplatin neurotoxicity in four patients. Cancer 94:2434-2440.